| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |